Taiwan ILD registry for understanding lung disease
Part of Lungs & breathing clinical trials.
This registry is gathering information from people with different types of interstitial lung disease (ILD) across Taiwan. It aims to better understand the disease and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need a diagnosis of interstitial lung disease (ILD) from a specialist.
- Your ILD can be linked to conditions like idiopathic pulmonary fibrosis, connective tissue disease, drug reactions, or others like sarcoidosis or LAM.
- You must be able to give your informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with interstitial lung disease to learn more about how Chinese medicine can help. If you have ILD and are 18 or older, you may be able to join.
This study collects health information and may store blood or other samples to learn more about interstitial lung disease (ILD) and autoimmune-related conditions. Joining could help researchers understand different causes of ILD and improve future care.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
This study looks at people aged 18 and older who have a connective tissue disease and lung involvement. It aims to better understand how these lung problems progress and may help doctors choose better care.
This study builds a “biobank,” a storage of blood and related samples, from people with lung interstitial lung diseases or other lung scarring diseases. Your samples help researchers study these conditions and improve future care.
This study builds a community registry to learn about people affected by pulmonary fibrosis and related lung conditions, including patients, caregivers, and close family. By joining, you help researchers better understand needs and experiences in the real world.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.